Danielle Antalffy

Q: What is Danielle Antalffy's success rate?

Danielle Antalffy currently has a success rate of 85.66668764168688.

Q: What is the average return of Danielle Antalffy's calls?

Their stock ratings have generated an average return of 38.67578327811563.

UBS | Healthcare

Danielle Antalffy is an analyst from UBS specializing in the Healthcare sector. Ranked #904 out of 4771 analysts, they have issued 29 stock ratings with a success rate of 85.67% and an average return of 38.68%.

Danielle Antalffy has a well-established track record, with 29 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 85.67% and an average return of 38.68%, underscoring their expertise and ability to identify winning opportunities for investors.

#904

Out of 4771

Total Ratings

+85.67%

Success Rate

+38.68%

Average Return

Recent Ratings Analysis

PRCT

Hold

Jul 28, 2026

Target

$20.00

Current

$20.07

Performance

11.01%

Danielle Antalffy rated PRCT as Neutral on Jul 28, 2026, setting a price target of 20. Despite the Hold call, shares climbed 11.01% to 20.07, revealing unexpected momentum.

GKOS

Hold

Jul 28, 2026

Target

$150.00

Current

$170.38

Performance

12.59%

On Jul 28, 2026, GKOS was given a Neutral rating by Danielle Antalffy, with a target price of 150. The stock rallied from 170.38 to 170.38 after the Hold rating, surprising to the upside.

ENOV

Buy

Jul 28, 2026

Target

$51.00

Current

$18.41

Performance

-37.64%

ENOV received a Buy rating from Danielle Antalffy on Jul 28, 2026, aiming for 51. The rating hasn’t played out as hoped, with the stock trading 37.64% below expectations.

SYK

Hold

Mar 17, 2026

Target

$380.00

Current

$270.01

Performance

-22.66%

On Mar 17, 2026, Danielle Antalffy published a Neutral outlook on SYK, with a target of 380. Weakness in the stock, now at 270.01, supported the conservative rating.

BSX

Buy

Mar 17, 2026

Target

$105.00

Current

$43.10

Performance

-39.47%

Danielle Antalffy on Mar 17, 2026 assigned BSX a Buy rating, with a price target of 105. The call has struggled to gain traction, with shares losing 39.47%.

SGHT

Buy

Mar 06, 2026

Target

$12.00

Current

$8.01

Performance

115.77%

On Mar 06, 2026, Danielle Antalffy reaffirmed SGHT with a Buy rating, targeting 12. The recommendation was supported by strong follow-through as the stock rose from 8.005 to 8.005.

RXST

Hold

Feb 26, 2026

Target

$9.00

Current

$5.96

Performance

-24.75%

RXST was rated Neutral by Danielle Antalffy on Feb 26, 2026, with a price objective of 9. Investors who stayed cautious avoided some of the 24.75% decline.

TNDM

Hold

Feb 20, 2026

Target

$22.00

Current

$18.31

Performance

-25.48%

On Feb 20, 2026, Danielle Antalffy initiated coverage on TNDM with a Neutral rating and target of 22. The rating matched the stock’s inability to hold above 18.31.

ATRC

Buy

Feb 18, 2026

Target

$60.00

Current

$52.96

Performance

64.17%

Danielle Antalffy issued a Buy recommendation for ATRC on Feb 18, 2026, price target set at 60. Investors following the Buy call captured upside momentum, with shares now at 52.96.

ZBH

Sell

Jan 28, 2026

Target

$86.00

Current

$92.44

Performance

7.85%

On Jan 28, 2026, ZBH was evaluated by Danielle Antalffy, who gave a Sell rating and target of 86. Investors benefited from heeding the Sell stance, avoiding a 7.85% decline.

EW

Hold

Jan 12, 2026

Target

$95.00

Current

$86.77

Performance

4.53%

Danielle Antalffy rated EW as Neutral on Jan 12, 2026, setting a price target of 95. The Hold stance appears justified, as shares hovered around 86.77 with a 4.53% move.

INSP

Hold

Dec 23, 2025

Target

$91.00

Current

$68.12

Performance

-28.28%

On Dec 23, 2025, INSP was given a Neutral rating by Danielle Antalffy, with a target price of 91. The rating provided protection from downside risk as the stock fell to 68.12.

PODD

Buy

Nov 19, 2025

Target

$400.00

Current

$134.68

Performance

-61.12%

PODD received a Buy rating from Danielle Antalffy on Nov 19, 2025, aiming for 400. The rating hasn’t played out as hoped, with the stock trading 61.12% below expectations.

MDT

Hold

Nov 19, 2025

Target

$102.00

Current

$91.62

Performance

-8.69%

On Nov 19, 2025, Danielle Antalffy published a Neutral outlook on MDT, with a target of 102. Weakness in the stock, now at 91.62, supported the conservative rating.

TMCI

Hold

Nov 07, 2025

Target

$5.85

Current

$4.35

Performance

-2.68%

Danielle Antalffy on Nov 07, 2025 assigned TMCI a Neutral rating, with a price target of 5.85. The Hold stance reflected consolidation, as shares held near 4.35.

INMD

Hold

Nov 06, 2025

Target

$16.00

Current

$14.77

Performance

2.29%

On Nov 06, 2025, Danielle Antalffy reaffirmed INMD with a Neutral rating, targeting 16. The neutral call matched muted market action of 2.29%.

DXCM

Buy

Nov 03, 2025

Target

$95.00

Current

$84.51

Performance

39.85%

DXCM was rated Buy by Danielle Antalffy on Nov 03, 2025, with a price objective of 95. A bullish response from the market helped close the gap of 10.49 to the target.

BAX

Hold

Oct 31, 2025

Target

$21.00

Current

$24.18

Performance

30.91%

On Oct 31, 2025, Danielle Antalffy initiated coverage on BAX with a Neutral rating and target of 21. The Hold stance underestimated the stock’s strength as it gained 30.91%.

ISRG

Hold

Oct 23, 2025

Target

$600.00

Current

$360.46

Performance

-34.62%

Danielle Antalffy issued a Neutral recommendation for ISRG on Oct 23, 2025, price target set at 600. Market action validated the conservative Hold outlook with shares at 360.46.

JNJ

Buy

Oct 14, 2025

Target

$214.00

Current

$266.35

Performance

39.56%

On Oct 14, 2025, JNJ was evaluated by Danielle Antalffy, who gave a Buy rating and target of 214. This case illustrates how a timely bullish rating can translate into tangible gains of 39.56%.

ABT

Buy

Jan 23, 2025

Target

$148.00

Current

$103.37

Performance

-16.11%

Danielle Antalffy rated ABT as Buy on Jan 23, 2025, setting a price target of 148. The stock has underperformed, dropping 16.11% despite the bullish target of 148.

Frequency Asked Questions

Who is Danielle Antalffy?

Danielle Antalffy is an analyst from UBS specializing in the Healthcare sector.

What is Danielle Antalffy's success rate?

Danielle Antalffy currently has a success rate of +85.67%.

How many ratings has Danielle Antalffy issued?

Danielle Antalffy has issued 29 stock ratings so far.

What is the average return of Danielle Antalffy's calls?

Their stock ratings have generated an average return of +38.68%.

What is Danielle Antalffy's ranking?

Danielle Antalffy is ranked #904 out of 4771 analysts.

What types of ratings does Danielle Antalffy give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Danielle Antalffy?

You can follow Danielle Antalffy by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Danielle Antalffy?

Their latest rating was a Hold on PRCT issued on 2026-07-28.